Andrew M. Lippa
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Bacterial Genetics and Biotechnology, RNA and protein synthesis mechanisms, Bacterial biofilms and quorum sensing, Herpesvirus Infections and Treatments, Bacteriophages and microbial interactions
Most-Cited Works
- → Feedback Inhibition in the PhoQ/PhoP Signaling System by a Membrane Peptide(2009)246 cited
- → Antimicrobial peptides trigger a division block in Escherichia coli through stimulation of a signalling system(2016)71 cited
- → Mutant Kinesin-2 Motor Subunits Increase Chromosome Loss(2005)59 cited
- → Perturbation of the Oxidizing Environment of the Periplasm Stimulates the PhoQ/PhoP System in Escherichia coli(2012)58 cited
- → H‐NS‐like proteins in Pseudomonas aeruginosa coordinately silence intragenic transcription(2020)24 cited
- → Congenital heart defects in oculodentodigital dysplasia: Report of two cases(2013)20 cited
- → Novel anti-repression mechanism of H-NS proteins by a phage protein(2021)14 cited
- → The N Terminus of Adenovirus Type 12 E1A Inhibits Major Histocompatibility Complex Class I Expression by Preventing Phosphorylation of NF-κB p65 Ser 276 through Direct Binding(2010)10 cited
- → Glycoprotein C of herpes simplex virus type 1 is required to cause keratitis at low infectious doses in intact rabbit corneas(2004)8 cited
- → Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers(2023)5 cited